Shire PLC’s (SHP) Outperform Rating Reaffirmed at BNP Paribas
BNP Paribas reiterated their outperform rating on shares of Shire PLC (LON:SHP) in a research note published on Friday. They currently have a GBX 5,900 ($77.01) price target on the biopharmaceutical company’s stock.
A number of other equities analysts also recently issued reports on the company. Goldman Sachs Group Inc. restated a conviction-buy rating and issued a GBX 6,300 ($82.23) price target on shares of Shire PLC in a research note on Thursday. Shore Capital reaffirmed a buy rating on shares of Shire PLC in a report on Wednesday, September 28th. HSBC decreased their target price on Shire PLC from GBX 5,250 ($68.53) to GBX 5,200 ($67.88) and set a hold rating on the stock in a report on Wednesday, September 28th. Berenberg Bank reaffirmed a buy rating and issued a GBX 5,800 ($75.71) target price on shares of Shire PLC in a report on Tuesday, September 27th. Finally, Citigroup Inc. reaffirmed a buy rating on shares of Shire PLC in a report on Tuesday, September 27th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Shire PLC currently has a consensus rating of Buy and an average price target of GBX 5,828 ($76.07).
Shire PLC (LON:SHP) traded up 1.00% during mid-day trading on Friday, hitting GBX 5048.00. The company had a trading volume of 896,990 shares. The company’s market capitalization is GBX 34.47 billion. The firm’s 50 day moving average is GBX 4,983.22 and its 200 day moving average is GBX 4,511.67. Shire PLC has a 52 week low of GBX 2,707.19 and a 52 week high of GBX 5,377.00.
The firm also recently declared a dividend, which will be paid on Friday, October 7th. Stockholders of record on Thursday, September 8th will be given a dividend of GBX 3.51 ($0.05) per share. This represents a dividend yield of 0.07%. The ex-dividend date of this dividend is Thursday, September 8th.
In other Shire PLC news, insider Dominic Blakemore purchased 133 shares of Shire PLC stock in a transaction dated Friday, September 30th. The shares were acquired at an average cost of GBX 5,010 ($65.40) per share, with a total value of £6,663.30 ($8,697.69).
Shire PLC Company Profile
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.
Receive News & Stock Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related stocks with our FREE daily email newsletter.